Stockscreener 앱 받기
13.80
0.36%
0.05
시간 외 거래:
13.66
-0.14
-1.01%
전일 마감가:
$13.75
열려 있는:
$13.67
하루 거래량:
29,878
Relative Volume:
0.72
시가총액:
$339.00M
수익:
$59,000
순이익/손실:
$-21.81M
주가수익비율:
-1.2601
EPS:
-10.9518
순현금흐름:
$-18.07M
1주 성능:
+3.99%
1개월 성능:
-14.34%
6개월 성능:
+24.44%
1년 성능:
+97.42%
1일 변동 폭
$13.50
$14.13
1주일 범위
$13.26
$14.22
52주 변동 폭
$5.742
$16.90
Benitec Biopharma Inc Stock (BNTC) Company Profile
명칭
Benitec Biopharma Inc
전화
(510) 780-0819
주소
3940 TRUST WAY, HAYWARD, CA
BNTC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BNTC
Benitec Biopharma Inc
|
13.80 | 339.00M | 59,000 | -21.81M | -18.07M | -10.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-16 | 개시 | H.C. Wainwright | Buy |
| 2024-12-13 | 개시 | Robert W. Baird | Outperform |
| 2024-10-16 | 개시 | Oppenheimer | Outperform |
| 2024-09-12 | 개시 | Guggenheim | Buy |
| 2024-07-22 | 개시 | Leerink Partners | Outperform |
| 2024-06-13 | 개시 | Piper Sandler | Overweight |
| 2020-10-05 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2020-04-20 | 개시 | Ladenburg Thalmann | Buy |
| 2016-02-26 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2015-12-31 | 재확인 | Maxim Group | Buy |
| 2015-09-16 | 재확인 | Maxim Group | Buy |
모두보기
Benitec Biopharma Inc 주식(BNTC)의 최신 뉴스
(BNTC) Long Term Investment Analysis - news.stocktradersdaily.com
Are Medical Stocks Lagging Ascendis Pharma (ASND) This Year? - Yahoo Finance
Benitec Biopharma: An Under-The-Radar And Undervalued Gene Therapy Developer - Seeking Alpha
JMP Securities Boosts Benitec Biopharma (NASDAQ:BNTC) Price Target to $20.00 - Defense World
Benitec Biopharma (BNTC) Stock Price Target Increased Amid Promi - GuruFocus
Benitec stock price target raised to $20 at JMP Securities - Investing.com Australia
Benitec stock price target raised to $20 at JMP Securities By Investing.com - Investing.com India
Benitec Biopharma Inc. (NASDAQ:BNTC) Given Average Rating of “Buy” by Brokerages - Defense World
Q3 EPS Forecast for Benitec Biopharma Boosted by Analyst - Defense World
Suvretta capital management buys $211,736 in Benitec Biopharma shares By Investing.com - Investing.com Canada
Insiders Are Loving These 5 Tech and Biotech Stocks - 24/7 Wall St.
Discover the Top 5 Small-Cap Biotech Stocks in 2025 - Investing News Network
Top 5 Small-cap Biotech Stocks of 2025 - Nasdaq
Benitec Biopharma Inc. (NASDAQ:BNTC) Director Suvretta Capital Management, L Buys 900,000 Shares of Stock - MarketBeat
Benitec Biopharma completes stock and warrant offerings By Investing.com - Investing.com Australia
Suvretta capital purchases $11.7m in Benitec Biopharma shares By Investing.com - Investing.com India
Major Investment Alert: Benitec Biopharma Stock Purchase Shakes the Market! - TipRanks
Benitec Biopharma completes stock and warrant offerings - Investing.com India
Suvretta capital purchases $11.7m in Benitec Biopharma shares - Investing.com
Benitec Biopharma inks deal granting stock resale rights - Investing.com India
Benitec Biopharma inks deal granting stock resale rights By Investing.com - Investing.com Canada
Benitec Biopharma prices $30M securities offerings - MSN
Benitec Biopharma Inc. Announces Pricing of $30 Million Common Stock Offering - GlobeNewswire
Benitec Biopharma prices 1.44M shares at $13.00 in underwritten offering - TipRanks
Benitec Biopharma Prices $30 Million Equity Offerings - MarketScreener
(BNTC) Trading Report - news.stocktradersdaily.com
Benitec Biopharma (NASDAQ:BNTC) Receives Buy Rating from HC Wainwright - Defense World
H.C. Wainwright maintains Buy on Benitec BioPharma stock By Investing.com - Investing.com Australia
H.C. Wainwright maintains Buy on Benitec BioPharma stock - Investing.com
Micron Technology, Nike, FedEx And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Benitec Biopharma Inc. (NASDAQ:BNTC) Short Interest Up 17.6% in February - Defense World
Benitec Biopharma stock soars to 52-week high of $16.2 By Investing.com - Investing.com Australia
Benitec Biopharma stock soars to 52-week high of $16.2 - Investing.com
Benitec reports progress in OPMD swallowing function study By Investing.com - Investing.com South Africa
Benitec Biopharma Reports Positive Interim Results For BB-301 Gene Therapy In OPMD Clinical Trial - RTTNews
Benitec Biopharma’s SWOT analysis: gene therapy stock shows promise in OPMD By Investing.com - Investing.com South Africa
Benitec Biopharma’s SWOT analysis: gene therapy stock shows promise in OPMD - Investing.com
Benitec Biopharma Announces Positive Interim Results for BB-301 - TipRanks
Benitec reports progress in OPMD swallowing function study - Investing.com India
Benitec Biopharma Reports Positive Interim Clinical Results for Three Subjects Treated with BB-301 in Phase 1b/2a Study to be Presented at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference - The Manila Times
Benitec Biopharma Reports Positive Interim Clinical Results for Three Subjects Treated with ... - The Bakersfield Californian
Benitec Biopharma Reports Positive Interim Clinical Results - GlobeNewswire
Benitec stock holds $18 target, Market Outperform rating By Investing.com - Investing.com UK
Benitec Biopharma Inc. (NASDAQ:BNTC) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Benitec Biopharma Inc (BNTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.15%
4.32%
자본화:
|
볼륨(24시간):